Trials / Conditions / Cold Agglutinin Disease

Cold Agglutinin Disease

10 registered clinical trials studyying Cold Agglutinin Disease — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias NCT05757570	Alpine Immune Sciences, Inc.	Phase 1 / Phase 2
Completed	A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD) NCT05096403	Swedish Orphan Biovitrum	Phase 3
Completed	Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 NCT05132127	Sanofi	Phase 3
Recruiting	Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune NCT05931718	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	—
Completed	A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin NCT03347422	Bioverativ, a Sanofi company	Phase 3
Completed	Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemol NCT03226678	Apellis Pharmaceuticals, Inc.	Phase 2
Completed	Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease NCT02689986	Helse Fonna	Phase 2
Completed	Therapy of Chronic Cold Agglutinin Disease With Eculizumab NCT01303952	University Hospital, Essen	Phase 2
Completed	The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders NCT00960713	University Hospital, Toulouse	—
Completed	Therapy for Chronic Cold Agglutinin Disease NCT00373594	University of Bergen	Phase 2